![Chemical structure of 2H-Benzo[a]quinolizin-2-one,1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, CAS 718635-93-9](https://api.angenesci.com/assets/img/none.png)
无数据
无数据
无数据
| CAS Number | 718635-93-9 |
| Catalog Number | AG00FC2R(AGN-PC-0TZHQ7) |
| Chemical Name | 2H-Benzo[a]quinolizin-2-one,1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)- |
| IUPAC Name | 9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one |
| InChI | InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3 |
| InChI Key | MKJIEFSOBYUXJB-UHFFFAOYSA-N |
| MDL Number | MFCD00042740 |
| Molecular Formula | C19H27NO3 |
| Molecular Weight | 317.4226 |
| SMILES | O=C(C(CC(C)C)C1)CC2N1CCC3=C2C=C(OC)C(OC)=C3 |
| Synonyms | Nitoman,
Tetrabenazine,
Xenazine,
TETRABENAZINE,
58-46-8,
Nitoman,
Tetrabenzaine,
Rubigen,
718635-93-9,
Tetrabenzine,
Xenazine,
Tetrabenazinum,
tetra Benazin,
Tetrabenazinum [INN-Latin],
Tetrabenazina [INN-Spanish],
3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one,
Ro 1-9569,
Tetrabenazine Racemate,
Tetrabenazine (Racemate),
Tetrabenazina,
NSC 169886,
9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one,
MLS003106727,
Ro 1-9569/12,
CHEMBL117785,
Tetrabenazine [INN:BAN],
CHEBI:64028,
MKJIEFSOBYUXJB-UHFFFAOYSA-N,
1,3,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo(a)quinolizin-2-one,
Ro-19569,
2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine,
9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-one,
NCGC00160421-01,
AK141500,
1,2,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one,
2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-,
9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one,
DSSTox_CID_22614,
DSSTox_RID_80059,
DSSTox_GSID_42614,
EINECS 200-383-6,
2-oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine,
2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-,
2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-,
3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one,
9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one,
BRN 0040090,
CAS-58-46-8,
Xenazine (TN),
2H-Benzo[a]quinolizin-2-one,1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-,(3R,11bR)-rel-,
SMR000718664,
Nitoman (TN),
AI3-52046,
2-Oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11-beta-hexahydro-2H-benzoquinolizine,
WLN: T B666 DV GNTT&J E1Y1&1 LO1 MO1,
Tetrabenazin,
Revocon,
2-Oxo-3-isobutyl-9,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine,
Nitoman;Xenazine,
2-Oxo-3-isobutyl-9,3,4,6,7,11.beta.-hexahydro-2H-benzoquinolizine,
1,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one,
2H-Benzo[a]quinolizin-2-one,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-,
2H-Benzo[a]quinolizin-2-one,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-,
9,10-Dimethoxy-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one,
2,3-dimethoxy-9-(2-methylpropyl)-5,6,7,11a-tetrahydropiperidino[2,1-a]isoquino lin-10-one,
Tetrabenazine(Racemate),
AC1L1LMF,
Tetrabenazine (JAN/INN),
TimTec1_002217,
Oprea1_264344,
SCHEMBL62026,
MLS001249426,
MLS001249497,
GTPL4834,
DTXSID0042614,
CTK8E8809,
HY-B0590A,
HMS1540E17,
HMS2966E06,
HMS3263I14,
HMS3430F03,
Tetrabenazine (Nitoman, Xenazine),
(3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one,
(3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one,
1026016-84-1,
ACT06890,
BCP24156,
EX-A2361,
KS-00001F7Q,
Tox21_111803,
Tox21_501086,
BDBM50017701,
BN0515,
MFCD00042740,
MFCD08461052,
NSC169886,
NSC172187,
s1789,
SBB018797,
STK678061,
AKOS001681311,
AKOS016347602,
Tox21_111803_1,
API0004368,
CCG-118217,
CS-5700,
DB04844,
LP01086,
MCULE-5822627411,
NSC-169886,
NSC-172187,
PB21652,
1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-Benzo[a]quinolizin-2-one,
NCGC00160421-02,
NCGC00160421-03,
NCGC00261771-01,
AN-41756,
AS-35785,
BC201335,
LS-40294,
SC-20416,
ST028814,
AB0073774,
AB2000294,
AX8281672,
TC-062470,
TL8005032,
FT-0674921,
FT-0700948,
Z3433,
C11168,
D08575,
Q-2641,
SR-01000833864,
SR-01000833864-4,
BRD-A47564106-001-01-8,
Z1563146114,
A2708/0115225,
2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizine,
2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7, 11b-hexahydro-3-isobutyl-9,10-dimethoxy-,,
3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one #,
3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-pyrido[2,1-a]isoquinolin-2-one,
3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one,
3-isobutyl-9-,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizin-2-one,
2h-benzo[a]quinolizin-2-one,1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-,(3r,11br)-rel,
Tetrabenazine, racemic mixture|||9,10-Dimethoxy-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one,
Regulin,
tetrabenazin-,
Tetrabenazine (INN),
Tetrabenazine [BAN:INN],
D09PJX,
UNII-Z9O08YRN8O,
C19H27NO3,
Nitoman, Xenazine, Tetrabenazine,
CID6018,
C19-H27-N-O3,
ACN-052006,
5-21-13-00178 (Beilstein Handbook Reference),
D013747,
Tetrabenazine, 99%, a VMAT-inhibitor - 1G 1g,
TBZ,
1,3,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one,
2-Oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11.beta.-hexahydro-2H-benzoquinolizine,
(3R,11bR)-rel-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one,
1026016-83-0,
2H-benzo [a] quinolizin-2-ona, 1,3,4,6,7,11 b-hexahidro-9,10-dimetoxi-3-(2-metilpropil)-, (3R, 11bR)-rel-,
2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-(9CI),
2H-BENZO[A]QUINOLIZIN-2-ONE, 1,3,4,6,7,11B-HEXAHYDRO-9,10-DIMETHOXY-3-(2-METHYLPROPYL)-, (3R,11BR)-REL-,
|
| Complexity | 425 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 317.199g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 23 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 317.429g/mol |
| Monoisotopic Mass | 317.199g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 38.8A^2 |
| Undefined Atom Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.9 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

